耐信上市了吗？

(Nexium) is mainly used to treat peptic ulcers. Compared with other proton pump inhibitors, esomeprazole has the advantages of shorter course of treatment, more stable efficacy, faster and longer onset of action, and higher HP ulcer eradication rate. It is the latest generation of drugs currently used to treat peptic ulcers. In late June 2014, Nexium capsules (Lamisu), a national Class 4 new drug independently developed by Laimei Pharmaceutical, was officially launched on the market, which means that the 15-year research and development of Nexium new drug, which started in 1999, was declared successful.

According to sample hospital sales data from the Southern Institute of Medical Economics, digestive system drug sales exceeded $27 billion in 2012, a year-on-year increase of about 13%. Among them, PPI drugs account for about 70% of the market share. Nexium, a new generation of PPI drugs, is in a period of rapid growth. Among the sales of terminal digestive system drugs in sample hospitals in 2013 by the Southern Medical Research Institute, Nexium's market share reached 3.76%, with the fastest growth rate.

It is understood that the only Nexium drugs currently sold in my country are imported varieties from the international pharmaceutical giant AstraZeneca, and there are no other domestic manufacturers. Laimei Pharmaceutical independently developed Nexium, breaking the monopoly of foreign pharmaceutical companies. According to my country's current pharmaceutical approval system, Nexium capsules have a three-year monitoring and protection period. In the next three years, Laimei Pharmaceutical will have the exclusive right to produce and sell Nexium capsules in my country.

The above is the listing status of Nexium provided by our Medical Travel Overseas Medical Consulting Service Company. Nexium has long been on the market in my country and has been included in medical insurance. This move has greatly reduced the burden of drug purchase for patients with gastric ulcer and gastric disease in my country. If you have any other questions, please consult the medical companion passenger service.